tm logo
JERINI
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 20 May 2011

Last Applicant/ Owned by

BERLIN FED. REP.

DD

Serial Number

76272025 filed on 15th Jun 2001

Registration Number

2894095 registered on 19th Oct 2004

in the Principal Register

Correspondent Address

Matthew J. Smith

Matthew J. Smith

Suite 1100

100 S. Fourth St.

St. Louis MO 63102

Filing Basis

1. intent to use

Disclaimer

NO DATA

JERINI

Chemical processing or transformation of inorganic or organic compounds for third parties, namely synthesis of peptides, polypeptides and proteins, manufacture of immobilized enzyme substrates, proteinmimetica and peptidimimetica, synthesis of peptides with sterically hindered amino acids, synthesis of peptides with distinct secondary structures and/or multiple antigenic peptides, immobilization o Read More

Classification Information


Class [001]
Chemical Products


Chemicals used in industry and science, agriculture, horticulture and forestry, namely, proteins, peptides, peptidomimetics, small molecules, nucleic acids and polynucleotides; proteins and recombinant proteins for scientific research use; peptides for scientific research use; antibodies for scientific research use; DNA probes for scientific research use; oligonucleotides for scientific research use; antisense constructs for scientific research use; arrays of nucleic acids on a carrier material for scientific research use; arrays of proteins on a carrier material for scientific research use; arrays of peptides on a carrier material for scientific research use

Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary products, namely, preparations for sanitation, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgesics and antirheumatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolytics, hemostatics, antihypertonics, antihypoglycemics, antihypotonics, anticoagulants, antimycotics, pharmaceuticals functioning as antiparasitics, antiphlogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin-system, pharmaceuticals functioning as broncholytics, antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anesthetics, neural therapeutics, gastrointestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use in osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies, and medical plastics, namely sanitary preparations, veterinary preparations for use in the treatment of diseases of pets, livestock, wild animals, breeding animals and zoo animals; dietic supplements adapted for medical use, namely food for elderly people and for medically restricted diets; all-purpose disinfectants; preparations for destroying vermin; fungicides for domestic use; fungicides for agricultural use; herbicides for domestic use; herbicides for agricultural use; medicaments against artheriosclerosis; medicaments against restenosis; medicaments for tissue regeneration and tissue replacement; medicaments for cartilage regeneration; pharmaceutical and veterinary preparations for diabetes treatment; pharmaceutical and veterinary preparations for diabetes prophylaxis; medicaments against obesity; pharmaceutical and veterinary preparations for use in pets, livestock, wild animals, breeding animals and zoo animals against tumors; peptides for medical use; peptides for medical diagnostic use; peptidomimetics for medical use; peptiomimetics for medical diagnostic use; antibodies for medical use; antibodies for medical diagnostic use; DNA probes for medical use; DNA probes for medical diagnostic use; oligonucleotides for medical use; oligonucleotides for medical diagnostic use; small molecules for medical use

Class [009]
Computer & Software Products & Electrical & Scientific Products


Scientific control apparatus and instruments, namely microscopes, ELISA readers, scanners, fluorescence readers, and phosphorimagers; scientific measuring and checking apparatus and instruments, comprising filters and membranes used in the field of biotechnology and pharmaceuticals; computer programs for synthesis of chemicals used in industry and science; computer programs for immobilization of chemicals used in industry and science; computer programs for analysis of patterns on surfaces, namely for analysis of filters and membranes; computer programs for the screening of compounds

Class [040]
Treatment & Processing of Materials Services


Chemical processing or transformation of inorganic or organic compounds for third parties, namely synthesis of peptides, polypeptides and proteins, manufacture of immobilized enzyme substrates, proteinmimetica and peptidimimetica, synthesis of peptides with sterically hindered amino acids, synthesis of peptides with distinct secondary structures and/or multiple antigenic peptides, immobilization of products and compounds, compound libraries, enzyme substrates, proteinmimetica and peptidomimetica, modification of peptides and proteins, and transformation of biologically active peptides and peptidomimetica

Class [042]
Computer & Software Services & Scientific Services


Laboratory services of a chemist, biologist, biochemist, biotechnologists, gene technologists, molecular biologists, pharmacists, medical doctor, protein chemist; scientific and industrial research; computer programming

Mark Details


Serial Number

No 76272025

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th May 2011CANCELLED SEC. 8 (6-YR)
03rd Feb 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03rd Feb 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24th Oct 2007REVIEW OF CORRESPONDENCE COMPLETE
18th Oct 2007PAPER RECEIVED
11th Dec 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Nov 2004PAPER RECEIVED
08th Nov 2004PAPER RECEIVED
19th Oct 2004REGISTERED-PRINCIPAL REGISTER
19th Oct 2004EXPARTE APPEAL TERMINATED